← Leaderboards
Thomas Reiner
Sloan-Kettering Inst Can Research
$4,804,085
Attributed
$7,319,093
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2013–21$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$7,319,093 · 9
By mechanism
R01$5,744,901 · 4
R43$599,917 · 2
K25$524,718 · 1
R42$262,732 · 1
R21$186,825 · 1
Top collaborators
- Christian Brand3 shared
- Carlos PãRez-Medina3 shared
- Willem Mulder2 shared
- Wolfgang Weber2 shared
- Brett Stewart Carver1 shared
- Zahi A. Fayad1 shared
- Jan Grimm1 shared
- Snehal Patel1 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Jan Grimm$17,140,928
- Brett Stewart Carver$12,016,524
- Pankaj Chaturvedi$1,198,588
- Milind Rajadhyaksha$15,078,152
- Joseph G Jurcic$858,939
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseImageTumorIn VivoImaging AgentFluorescence ImagingDesignTissuesSmall MoleculeLeadMalignant NeoplasmsLibrariesSpecificityGrowthRadiochemistryDrug KineticsLabelSiteCompanionsMemorial Sloan-Kettering Cancer CenterMalignant - DescriptorDiagnosisMonitorMouse Model
Grant awards (19)
PSMAâs enzymatic activity as new target for Prostate Cancer diagnosis and therapy$734,548
R01 · FY2021 · CA
PET nanoreporter image-guided breast cancer therapy$724,049
R01 · FY2020 · CA
Development and validation of an intraoperative imaging agent for the peripheral nervous system$542,156
R01 · FY2020 · EB · contact PI
Non-Invasive Imaging of Oral Cavity Cancer$262,732
R42 · FY2020 · CA
PET nanoreporter image-guided breast cancer therapy$702,327
R01 · FY2019 · CA
Radioiodinated Multifunctional PARP1 Imaging Probes for Diagnosis and Therapy$515,195
R01 · FY2019 · CA · contact PI
Non-destructive and instant intraoperative margin assessment of high grade dysplasia and cancer of the cervix and vulva$300,000
R43 · FY2019 · CA
Radioiodinated Multifunctional PARP1 Imaging Probes for Diagnosis and Therapy$124,935
R01 · FY2019 · CA · contact PI
PET nanoreporter image-guided breast cancer therapy$758,800
R01 · FY2018 · CA
Radioiodinated Multifunctional PARP1 Imaging Probes for Diagnosis and Therapy$506,879
R01 · FY2018 · CA · contact PI
Rapid, quantitative and affordable point-of-care diagnostics for oral and oropharyngeal cancer$299,917
R43 · FY2018 · CA
Radioiodinated Multifunctional PARP1 Imaging Probes for Diagnosis and Therapy$122,254
R01 · FY2018 · CA · contact PI
Radioiodinated Multifunctional PARP1 Imaging Probes for Diagnosis and Therapy$506,879
R01 · FY2017 · CA · contact PI
Radioiodinated Multifunctional PARP1 Imaging Probes for Diagnosis and Therapy$506,879
R01 · FY2016 · CA · contact PI
Development of Nuclear Auger Emitters for Targeted Radiotherapy$84,921
R21 · FY2016 · CA · contact PI
Bioorthogonal Strategies for Targeted PET Imaging Probe Development$174,906
K25 · FY2015 · EB · contact PI
Development of Nuclear Auger Emitters for Targeted Radiotherapy$101,904
R21 · FY2015 · CA · contact PI
Bioorthogonal Strategies for Targeted PET Imaging Probe Development$174,906
K25 · FY2014 · EB · contact PI
Bioorthogonal Strategies for Targeted PET Imaging Probe Development$174,906
K25 · FY2013 · EB · contact PI